Suchergebnisse - "Gentile, Ivan"

PubPharm (345)

101

Pre-existing chronic kidney disease (CDK) was not associated with a severe clinical outcome of hospitalized COVID-19 : results of a case-control study in Southern Italy

enthalten in: Le infezioni in medicina | 2022

von Calò, F. | Russo, A. | Palamone, M. | +19

102

COVID-19 chest CT and laboratory features of B.1.617.2 (Delta variant) vs B.1.1.7 (Alpha variant) surge : a single center case-control study

enthalten in: Le infezioni in medicina | 2022

von Viceconte, G. | Ponsiglione, A. | Buonomo, A. | +11

103

Circulating tissue inhibitor of metalloproteinases 1 (TIMP-1) at COVID-19 onset predicts severity status

enthalten in: Frontiers in medicine | 2022

von Brusa, S. | Terracciano, D. | Bruzzese, D. | +9

104

mTOR Inhibitor Use Is Associated With a Favorable Outcome of COVID-19 in Patients of Kidney Transplant : Results of a Retrospective Study

enthalten in: Frontiers in medicine | 2022

von Pinchera, B. | Spirito, L. | Buonomo, A. | +10

105

Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients

in: Viruses | 2022

von Pinchera Biagio | Carrano Rosa | Schiano Moriello Nicola | +9

106

SARS-CoV-2 in Kidney Transplant Patients: A Real-Life Experience

in: Frontiers in Medicine | 2022

von Biagio Pinchera | Lorenzo Spirito | Lucia Ferreri | +36

107

Safety and efficacy of anti-SARS-CoV-2 monoclonal antibodies in pregnancy

enthalten in: Expert opinion on drug safety | 2022

von Buonomo, A. | Esposito, N. | Di Filippo, I. | +5

108

COVID-19 prophylaxis in immunosuppressed patients : Beyond vaccination

enthalten in: PLoS medicine | 2022

von Gentile, I. | Schiano Moriello, N.

109

A prospective study of direct‐acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort

enthalten in: Hepatology | 2022

von Kondili, L. | Monti, M. | Quaranta, M. | +30

110

Pneumocystis jirovecii pneumonia in COVID-19 : an overlooked clinical entity-Response to "Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19"

enthalten in: Critical care (London, England) | 2021

von Buonomo, A. | Viceconte, G. | Gentile, I.

CommentOn: Crit Care. 2021 Sep 26;25(1):348. - PMID 34565429